Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

CCM vs RDNT

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
CCM
Concord Medical Services Holdings Limited

Medical - Care Facilities

HealthcareNYSE • CN
Market Cap$748K
5Y Perf.-63.0%
RDNT
RadNet, Inc.

Medical - Diagnostics & Research

HealthcareNASDAQ • US
Market Cap$4.45B
5Y Perf.+237.4%

CCM vs RDNT — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
CCM logoCCM
RDNT logoRDNT
IndustryMedical - Care FacilitiesMedical - Diagnostics & Research
Market Cap$748K$4.45B
Revenue (TTM)$366M$2.04B
Net Income (TTM)$-163M$47M
Gross Margin-11.4%11.2%
Operating Margin-131.0%3.0%
Forward P/E1.2x91.8x
Total Debt$3.93B$1.86B
Cash & Equiv.$216M$767M

CCM vs RDNTLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

CCM
RDNT
StockMay 20May 26Return
Concord Medical Ser… (CCM)10037.0-63.0%
RadNet, Inc. (RDNT)100337.4+237.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: CCM vs RDNT

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: RDNT leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Concord Medical Services Holdings Limited is the stronger pick specifically for valuation and capital efficiency and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
CCM
Concord Medical Services Holdings Limited
The Income Pick

CCM is the clearest fit if your priority is income & stability and sleep-well-at-night.

  • Dividend streak 0 yrs, beta 0.53
  • Lower volatility, beta 0.53, current ratio 0.46x
  • Beta 0.53, current ratio 0.46x
Best for: income & stability and sleep-well-at-night
RDNT
RadNet, Inc.
The Growth Play

RDNT carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.

  • Rev growth 11.5%, EPS growth -7.7%, 3Y rev CAGR 12.6%
  • 9.5% 10Y total return vs CCM's -88.8%
  • 11.5% revenue growth vs CCM's -28.6%
Best for: growth exposure and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthRDNT logoRDNT11.5% revenue growth vs CCM's -28.6%
ValueCCM logoCCMLower P/E (1.2x vs 91.8x)
Quality / MarginsRDNT logoRDNT2.3% margin vs CCM's -44.6%
Stability / SafetyCCM logoCCMBeta 0.53 vs RDNT's 1.43
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)RDNT logoRDNT+4.6% vs CCM's -28.4%
Efficiency (ROA)RDNT logoRDNT1.3% ROA vs CCM's -2.4%, ROIC 2.0% vs -7.7%

CCM vs RDNT — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

CCMConcord Medical Services Holdings Limited
FY 2024
Services and other revenues
80.1%$372M
Medicine income
17.9%$83M
Equipment Leasing Revenues
2.0%$9M
RDNTRadNet, Inc.
FY 2025
Commercial Insurance1
58.8%$1.1B
Medicare1
24.8%$477M
Capitation Arrangements
6.5%$126M
Health Care, Other
3.4%$65M
Medicaid1
2.7%$52M
Workers' Compensation/Personal Injury1
2.3%$45M
Health Care, Management Service
1.4%$28M

CCM vs RDNT — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLRDNTLAGGINGCCM

Income & Cash Flow (Last 12 Months)

RDNT leads this category, winning 5 of 6 comparable metrics.

RDNT is the larger business by revenue, generating $2.0B annually — 5.6x CCM's $366M. RDNT is the more profitable business, keeping 2.3% of every revenue dollar as net income compared to CCM's -44.6%. On growth, RDNT holds the edge at +14.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricCCM logoCCMConcord Medical S…RDNT logoRDNTRadNet, Inc.
RevenueTrailing 12 months$366M$2.0B
EBITDAEarnings before interest/tax-$359M$214M
Net IncomeAfter-tax profit-$163M$47M
Free Cash FlowCash after capex$0-$178M
Gross MarginGross profit ÷ Revenue-11.4%+11.2%
Operating MarginEBIT ÷ Revenue-131.0%+3.0%
Net MarginNet income ÷ Revenue-44.6%+2.3%
FCF MarginFCF ÷ Revenue-2.1%-8.7%
Rev. Growth (YoY)Latest quarter vs prior year-8.3%+14.8%
EPS Growth (YoY)Latest quarter vs prior year+84.0%-114.1%
RDNT leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

CCM leads this category, winning 3 of 4 comparable metrics.
MetricCCM logoCCMConcord Medical S…RDNT logoRDNTRadNet, Inc.
Market CapShares × price$748,461$4.5B
Enterprise ValueMkt cap + debt − cash$547M$5.5B
Trailing P/EPrice ÷ TTM EPS-0.02x-230.00x
Forward P/EPrice ÷ next-FY EPS est.1.23x91.75x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple25.88x
Price / SalesMarket cap ÷ Revenue0.01x2.18x
Price / BookPrice ÷ Book value/share0.00x3.19x
Price / FCFMarket cap ÷ FCF52.01x
CCM leads this category, winning 3 of 4 comparable metrics.

Profitability & Efficiency

RDNT leads this category, winning 9 of 9 comparable metrics.

RDNT delivers a 3.8% return on equity — every $100 of shareholder capital generates $4 in annual profit, vs $-10 for CCM. RDNT carries lower financial leverage with a 1.37x debt-to-equity ratio, signaling a more conservative balance sheet compared to CCM's 2.43x. On the Piotroski fundamental quality scale (0–9), RDNT scores 5/9 vs CCM's 3/9, reflecting solid financial health.

MetricCCM logoCCMConcord Medical S…RDNT logoRDNTRadNet, Inc.
ROE (TTM)Return on equity-9.8%+3.8%
ROA (TTM)Return on assets-2.4%+1.3%
ROICReturn on invested capital-7.7%+2.0%
ROCEReturn on capital employed-12.2%+2.1%
Piotroski ScoreFundamental quality 0–935
Debt / EquityFinancial leverage2.43x1.37x
Net DebtTotal debt minus cash$3.7B$1.1B
Cash & Equiv.Liquid assets$216M$767M
Total DebtShort + long-term debt$3.9B$1.9B
Interest CoverageEBIT ÷ Interest expense-2.40x1.46x
RDNT leads this category, winning 9 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

RDNT leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in RDNT five years ago would be worth $24,710 today (with dividends reinvested), compared to $1,512 for CCM. Over the past 12 months, RDNT leads with a +4.6% total return vs CCM's -28.4%. The 3-year compound annual growth rate (CAGR) favors RDNT at 26.0% vs CCM's -27.2% — a key indicator of consistent wealth creation.

MetricCCM logoCCMConcord Medical S…RDNT logoRDNTRadNet, Inc.
YTD ReturnYear-to-date+20.4%-19.0%
1-Year ReturnPast 12 months-28.4%+4.6%
3-Year ReturnCumulative with dividends-61.4%+100.0%
5-Year ReturnCumulative with dividends-84.9%+147.1%
10-Year ReturnCumulative with dividends-88.8%+947.4%
CAGR (3Y)Annualised 3-year return-27.2%+26.0%
RDNT leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CCM and RDNT each lead in 1 of 2 comparable metrics.

CCM is the less volatile stock with a 0.53 beta — it tends to amplify market swings less than RDNT's 1.43 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. RDNT currently trades 67.0% from its 52-week high vs CCM's 47.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricCCM logoCCMConcord Medical S…RDNT logoRDNTRadNet, Inc.
Beta (5Y)Sensitivity to S&P 5000.53x1.43x
52-Week HighHighest price in past year$10.77$85.84
52-Week LowLowest price in past year$3.18$50.76
% of 52W HighCurrent price vs 52-week peak+47.7%+67.0%
RSI (14)Momentum oscillator 0–10067.551.3
Avg Volume (50D)Average daily shares traded11K822K
Evenly matched — CCM and RDNT each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates CCM as "Buy" and RDNT as "Buy".

MetricCCM logoCCMConcord Medical S…RDNT logoRDNTRadNet, Inc.
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$92.00
# AnalystsCovering analysts211
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises00
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%
Insufficient data to determine a leader in this category.
Key Takeaway

RDNT leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). CCM leads in 1 (Valuation Metrics). 1 tied.

Best OverallRadNet, Inc. (RDNT)Leads 3 of 6 categories
Loading custom metrics...

CCM vs RDNT: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is CCM or RDNT a better buy right now?

For growth investors, RadNet, Inc.

(RDNT) is the stronger pick with 11. 5% revenue growth year-over-year, versus -28. 6% for Concord Medical Services Holdings Limited (CCM). Analysts rate Concord Medical Services Holdings Limited (CCM) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — CCM or RDNT?

Over the past 5 years, RadNet, Inc.

(RDNT) delivered a total return of +147. 1%, compared to -84. 9% for Concord Medical Services Holdings Limited (CCM). Over 10 years, the gap is even starker: RDNT returned +947. 4% versus CCM's -88. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — CCM or RDNT?

By beta (market sensitivity over 5 years), Concord Medical Services Holdings Limited (CCM) is the lower-risk stock at 0.

53β versus RadNet, Inc. 's 1. 43β — meaning RDNT is approximately 169% more volatile than CCM relative to the S&P 500. On balance sheet safety, RadNet, Inc. (RDNT) carries a lower debt/equity ratio of 137% versus 2% for Concord Medical Services Holdings Limited — giving it more financial flexibility in a downturn.

04

Which is growing faster — CCM or RDNT?

By revenue growth (latest reported year), RadNet, Inc.

(RDNT) is pulling ahead at 11. 5% versus -28. 6% for Concord Medical Services Holdings Limited (CCM). On earnings-per-share growth, the picture is similar: Concord Medical Services Holdings Limited grew EPS -3. 6% year-over-year, compared to -768. 4% for RadNet, Inc.. Over a 3-year CAGR, RDNT leads at 12. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — CCM or RDNT?

RadNet, Inc.

(RDNT) is the more profitable company, earning 2. 3% net margin versus -80. 3% for Concord Medical Services Holdings Limited — meaning it keeps 2. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: RDNT leads at 3. 0% versus -138. 6% for CCM. At the gross margin level — before operating expenses — RDNT leads at 11. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is CCM or RDNT more undervalued right now?

On forward earnings alone, Concord Medical Services Holdings Limited (CCM) trades at 1.

2x forward P/E versus 91. 8x for RadNet, Inc. — 90. 5x cheaper on a one-year earnings basis.

07

Which pays a better dividend — CCM or RDNT?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

08

Is CCM or RDNT better for a retirement portfolio?

For long-horizon retirement investors, Concord Medical Services Holdings Limited (CCM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

53)). Both have compounded well over 10 years (CCM: -88. 8%, RDNT: +947. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between CCM and RDNT?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

CCM

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

RDNT

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 7%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform CCM and RDNT on the metrics below

Revenue Growth>
%
(CCM: -8.3% · RDNT: 14.8%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.